Filing Details
- Accession Number:
- 0001140361-16-087794
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-11-23 16:42:00
- Reporting Period:
- 2016-11-21
- Filing Date:
- 2016-11-23
- Accepted Time:
- 2016-11-23 16:42:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1221590 | Jacques Jean Bienaime | C/O Biomarin Pharmaceutical Inc. 770 Lindaro St. San Rafael CA 94901 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-11-21 | 69,744 | $26.49 | 240,426 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-11-21 | 69,744 | $87.56 | 170,682 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2016-11-22 | 69,743 | $26.49 | 240,425 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-11-22 | 69,743 | $85.69 | 170,682 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy Common Stock) | Disposition | 2016-11-21 | 69,744 | $0.00 | 69,744 | $26.49 |
| Common Stock | Stock Option (right to buy Common Stock) | Disposition | 2016-11-22 | 69,743 | $0.00 | 69,743 | $26.49 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 210,256 | 2011-11-12 | 2021-05-11 | No | 4 | M | Direct |
| 140,513 | 2011-11-12 | 2021-05-11 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 182,801 | Indirect | Shares held by Jean-Jacques Bienaime Family Trust |
Footnotes
- Trade made pursuant to a 10b5-1 plan executed on June 9, 2016. Mr. Bienaime's former spouse will receive the net proceeds from the shares sold in this transaction in connection with cash payments owed to her pursuant to a marital separation agreement between her and Mr. Bienaime.
- The amount of securities beneficially owned has been updated from the reporting person's prior Form 4 to reflect (a) changes in the form of ownership due to transfers made by the reporting person between accounts held directly and indirectly in the name of the Bienaime Family Trust and the Jean-Jacques Bienaime Family Trust and (b) an additional 4,357 shares beneficially owned by the reporting person pursuant to a reconciliation of the Company's records following the completion of the transfer of shares in connection with the reporting person's marital separation agreement.
- The price in column 4 is the weighted average price. The price actually received ranged from $86.74 to $89.59. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.
- The price in column 4 is the weighted average price. The price actually received ranged from $84.45 to $88.16. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.
- Reflects the number of stock options outstanding after the transaction from this specific stock option grant.
Billionaire Hedge Funds
